Inflammatory Bowel Disease
Clinical research in Crohn’s disease and ulcerative colitis centers on maintenance of remission, endoscopic response, and long-term control of moderate to severe intestinal inflammation. The portfolio also includes studies in pediatric Crohn’s disease, with attention to clinical and endoscopic outcomes.
- Moderately to severely active Crohn’s disease
- Ulcerative colitis
- Clinical remission
- Endoscopic remission
These programs reflect a focus on chronic gastrointestinal inflammation and disease control across adult and pediatric populations.
Hematologic Malignancies
The sponsor supports trials in relapsed and refractory multiple myeloma, including studies of combination regimens and comparisons with standard-of-care approaches. The research emphasis is on disease progression, treatment response, and survival outcomes in heavily pretreated patients.
- Relapsed and refractory multiple myeloma
- Combination therapy
- Standard of care regimens
- Progression-free outcomes
Multiple myeloma studies extend across monotherapy and combination treatment strategies in adult oncology.
Eosinophilic Esophageal Disease
Research in eosinophilic esophagitis focuses on long-term safety and tolerability in adults and adolescents affected by this chronic immune-mediated esophageal disorder. The clinical interest is centered on sustained disease management and symptom control.
- Eosinophilic esophagitis
- Adolescent and adult patients
- Long-term safety
- Tolerability
The portfolio addresses a specialized allergic and inflammatory condition with persistent esophageal involvement.
Immune-Mediated Therapy Development
Across its trials, the sponsor is active in immune-mediated disease and oncology research, with a consistent interest in agents evaluated for chronic inflammatory disorders and plasma cell malignancies. The studies include both adult and pediatric populations and span multiple countries and research sites.
- Immune-mediated disorders
- Oncology
- Adult and pediatric populations
- Multinational clinical research
The therapeutic scope includes gastroenterology, hematology, and esophageal inflammatory disease.
